AVITA MEDICAL LIMITED (“COMPANY”)
The Compliance and Corporate Governance Committee shall comprise a minimum of three (3) members.
The function of the committee is to assist the Board in fulfilling its responsibilities with respect to compliance and corporate governance by:
- monitoring compliance issues, particularly compliance with the continuous disclosure requirements of the ASX listing rules;
- reviewing and verifying the accuracy of all public releases to the ASX of material consequence, prior to release to the market; and
- reviewing and advising on procedures in place to record the Company’s activities and to ensure the safety of the Company’s records and assets.
The committee shall meet at least once a year and otherwise as required. Minutes of all meetings of the committee are to be kept and a report of actions taken to be given at each subsequent meeting of the full Board. Committee meetings will be governed by the same rules as set out in the Company’s constitution, as they apply to meetings of the Board.